Health Capability: Empirical Applications

Job market paper

Abstract: Addressing the multidimensionality of poverty is a major challenge in resource-limited settings where programs for health promotion often homogeneously target poor households. Following the collection of survey data in rural Senegal, I develop a structural equation model (SEM) to estimate and characterize three dimensions of health capability as conceptualized by Prah: self-reported health, empowerment, and healthcare access. In accounting for the multidimensionality of both poverty and health capability at the individual level, I highlight complex and sometimes contradictory effects. In particular, I provide novel evidence that empowerment, a key component of health capability, is lower in individuals living in resource-rich households, even though these individuals are more likely to report optimal levels in health and access to healthcare. My estimates emphasize a need to design differentiated policy and interventions for overall poverty reduction and health promotion. They also show how do to so through a comprehensive characterization of the socio-demographic and economic variables associated with distinct dimensions of health capability. 

 

Under review

Working paper

Work in progress


Publications

Peer-reviewed article

Book & book chapter

Chronic hepatitis B in rural Senegal

As project manager of the ANRS12356 AmBASS study (390,000€, PI: Sylvie Boyer & Aldiouma Diallo; 2017-2020), I coordinated the 4 scientific teams based in Dakar and Marseille, recruited and trained the field team of 8 interviewers and monitored data collection during the pilot and the main phase of the study, which administered at-home hepatitis B screening and socio-economic questionnaires to over 3,000 participants. I wrote the protocol paper and participated in the data analysis and scientific publications.  

I've also implemented and coordinated the PeCSen study (25,000€, PI: Sylvie Boyer; 2019-2022) which documented linkage to care among people screened for CHB during the AmBASS study. I set up data collection for monitoring visits in 3 health facilities, conducted a micro-costing study, and cooordinated a qualitative study among participants screened for CHB (n=40), and healthcare workers (n=15). 

I'm currently managing the data collection of a questionnaire among patients of the Sen-B prospective research cohort to document: (i) socio-economic resources, (ii) direct and indirect costs of CHB management, and (iii) patients reported outcomes. This data will enter an extended cost-effectiveness analysis of CHB management in centralized and decentralized settings in rural sub-Saharan Africa. 

Summary of results of the AmBASS survey: "Hépatite B: que retenir de l'étude AmBASS menée à Niakhar?"

Publications

Working papers

Work in progress

Access to care for people with substance use disorder in France (pre-doctoral work)

Evaluation of the Choizitaconso therapeutic evaluation program for people with alcohol use disorder (the ETHER study)

As a project coordinator, I co-designed the study and managed the funding application with ARS PACA (45,000€). I oversaw the application for ethical clearance, and co-organized training sessions in all three recruitment centers. In terms of research, I focused on the adaptation of the ICECAP-A instrument for measuring capability wellbeing and presented the study protocol at the 2019 iCEPS conference.

Publications

Poster: "Study protocol for the evaluation of a therapeutic education program for harm reduction in alcohol use disorder: a mixed method, community based approach" 2019 international Conference for the Evaluation of Non-Pharmaceutical Intervntions (iCEPS).

Access to antiviral drugs for hepatitis C among people who inject drugs (the FANTASIO study)

I oversaw the funding applications for phase 1 (171,000$) and phase 2 (103,000) of the study. I participated in the data analysis and presented a poster at the 2019 conference of the French Society of Hepatology (AFEF).

Publications

Poster: "Précédentes restrictions de prescription des antiviraux à action directe : quel effet sur l’accès au traitement VHC des populations-clés?" Conférence 2019 de l'AFEF.

Access to care for people with alcohol use disorder (the ASIA study)

I conducted the statistical analysis (quantitative data) alongside Tangui Barré, and contributed to drafting both manuscripts.

Publications